{
     "PMID": "2421657",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "19860522",
     "LR": "20141120",
     "IS": "0003-9780 (Print) 0003-9780 (Linking)",
     "VI": "279",
     "IP": "1",
     "DP": "1986 Jan",
     "TI": "Neurochemical effects of buspirone in rat hippocampus: evidence for selective activation of 5HT neurons.",
     "PG": "40-9",
     "AB": "The effect of buspirone on neurotransmitter systems in rat hippocampus has been evaluated in vitro and in vivo. In vitro buspirone does not affect the specific binding of 3H-flunitrazepam, 3H-GABA, 3H-dexetimide, but displaces 3H-5HT binding with nanomolar affinity. Oral administration of buspirone does not modify the hippocampal concentrations of GABA, acetylcholine, choline and of 3H-flunitrazepam specifically bound in vivo, but results in a dose-dependent reduction of 5HIAA and noradrenaline concentrations. While the effect on noradrenaline is also obtained in striatum of buspirone-treated animals, the effect on 5HIAA shows a regional specificity. The in vitro and in vivo data suggest that buspirone specifically activates 5HT neurons in hippocampus, and are compared with those obtained with diazepam.",
     "FAU": [
          "Mennini, T",
          "Gobbi, M",
          "Ponzio, F",
          "Garattini, S"
     ],
     "AU": [
          "Mennini T",
          "Gobbi M",
          "Ponzio F",
          "Garattini S"
     ],
     "LA": [
          "eng"
     ],
     "PT": [
          "Journal Article"
     ],
     "PL": "Belgium",
     "TA": "Arch Int Pharmacodyn Ther",
     "JT": "Archives internationales de pharmacodynamie et de therapie",
     "JID": "0405353",
     "RN": [
          "0 (Anti-Anxiety Agents)",
          "0 (Pyrimidines)",
          "0 (Receptors, Serotonin)",
          "333DO1RDJY (Serotonin)",
          "54-16-0 (Hydroxyindoleacetic Acid)",
          "56-12-2 (gamma-Aminobutyric Acid)",
          "620X0222FQ (Flunitrazepam)",
          "TK65WKS8HL (Buspirone)"
     ],
     "SB": "IM",
     "MH": [
          "Animals",
          "Anti-Anxiety Agents/*pharmacology",
          "Brain Chemistry/*drug effects",
          "Buspirone",
          "Flunitrazepam/metabolism",
          "Hippocampus/*metabolism",
          "Hydroxyindoleacetic Acid/metabolism",
          "In Vitro Techniques",
          "Neurons/drug effects/*metabolism",
          "Pyrimidines/*pharmacology",
          "Rats",
          "Receptors, Serotonin/drug effects",
          "Serotonin/*metabolism",
          "gamma-Aminobutyric Acid/metabolism"
     ],
     "EDAT": "1986/01/01 00:00",
     "MHDA": "1986/01/01 00:01",
     "CRDT": [
          "1986/01/01 00:00"
     ],
     "PHST": [
          "1986/01/01 00:00 [pubmed]",
          "1986/01/01 00:01 [medline]",
          "1986/01/01 00:00 [entrez]"
     ],
     "PST": "ppublish",
     "SO": "Arch Int Pharmacodyn Ther. 1986 Jan;279(1):40-9.",
     "term": "hippocampus"
}